A prospective cohort study found FABP4 levels increased remarkably in GDM groups from the second to the third trimester and were associated with a higher risk of GDM onset compared to other adipokines, such as leptin and retinol-binding protein 4 (RBP4) [32]. This evidence concerns the gene FABP4 and gestational diabetes.